Estimating the Cost per Clinical Outcome of Second-Line Liso-Cel Versus Autologous Stem Cell Transplantation in Patients with Transplantation-Intended Relapsed/Refractory Large B Cell Lymphoma

Saeedian, M; Badaracco, J; Botros, A; Gitlin, M; Keating, SJ

Botros, A (通讯作者)，US Field HEOR RWE Res, 3401 Princeton Pike, Lawrence Township, NJ 08648 USA.

TRANSPLANTATION AND CELLULAR THERAPY, 2023; 29 (11):

Abstract

It is important to consider the total cost of care (TCOC) associated with a therapy and clinical benefit for relapsed or refractory (R/R) large B cell......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索